CMS Ventures, established in 2020, is the corporate venture arm of China Medical System Holdings, located in Cambridge, United Kingdom. The firm specializes in the biotechnology and life sciences sectors, focusing on therapeutics, diagnostics, medical devices, and digital health. CMS Ventures actively engages with seed-stage, early-stage, and later-stage companies, providing not only financial investment but also essential support through evaluation, coaching, mentoring, and advisory services. The firm aims to foster growth within the biotech and life sciences ecosystem, primarily within the United Kingdom.
Build on Bitcoin is a hybrid Layer-2 network Bitcoin blockchain
Pact
Seed Round in 2022
Pact is a fintech platform that offers deep liquidity and low transaction fees. With accessible smart contract functionality, transactions on Pact are available to users of all levels of wealth and experience. It provides integration of financial assets on a non-custodial, decentralized platform intended to be the home of liquidity on Algorand. Pact was launched in 2021.
Qureight
Seed Round in 2021
Qureight is an imaging analytics company. It also aims to develop a new improved and streamlined version of its analytical platform – harnessing the ability of AI and advanced processing tools to gain new insights into respiratory diseases such as Idiopathic Pulmonary Fibrosis (IPF) and lung cancer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.